Upkar S. Gill

Duke-NUS Medical School — Singapore

Medicine · Health Sciences

31h-index5.9kcitations160works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(102), Hepatitis C virus research(84), Liver Disease Diagnosis and Treatment(62), Immune Cell Function and Interaction(24), Immunotherapy and Immune Responses(13)

Publications160 total

Author Correction: DC subsets and states unraveled across human juxtatumoral and malignant tissues
Nature Immunology·2026Open Access
A genes and health recall study of intrahepatic cholestasis of pregnancy and cholestatic liver disease
Communications Medicine·2025Open Access
Stem-like CD8+ T cells preserve HBV-specific responses in HBV/HIV co-infection
Gut·2025Open Access
Introducing <i>Gut Science—</i> a fundamental and discovery science companion journal to <i>Gut</i>
Gut·2025Open Access
Chronic hepatitis B in 2025: diagnosis, treatment and future directions
Clinical Medicine·2025· 2 citedOpen Access
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
Cytotherapy·2025Open Access
Fine needle aspirates characterise the hepatocellular carcinoma immune niche to predict immune checkpoint inhibitor outcomes
JHEP Reports·2025Open Access
‘What is new in hepatitis B’
Frontline Gastroenterology·2025
P162 Follow-up of patients with hepatitis C who achieved sustained virological response: a pharmacist-led service evaluation
2025
P159 Innate-like CD56 <sup>+</sup> CD8 <sup>+</sup> T cells exhibit bystander function and metabolic sensitivity in chronic hepatitis B
2025
Corrigendum to “Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response” [J Hepatol (2025) 101382]
JHEP Reports·2025Open Access
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
UNC Libraries·2025Open Access
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
UNC Libraries·2025Open Access
Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases
Journal of Hepatology·2025· 6 citedOpen Access
Mitigation of Immune Dysfunction in Patients with Sustained Suppression of Hepatitis B Surface Antigen After siRNA Treatment
EMJ Hepatology·2025· 1 citedOpen Access
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines
2025· 1 citedOpen Access
THU-207-YI Clinical follow up in patients treated for hepatitis C
Journal of Hepatology·2025
SAT-259 Long-term outcomes of 'Grey Zone’ (GZ) individuals living with HBeAg-negative chronic hepatitis B in a tertiary UK centre
Journal of Hepatology·2025
TOP-015 Emergency department opt out testing for HBV and HCV in London with integrated linkage to care: an effective initiative to diagnose hepatitis or work in progress?
Journal of Hepatology·2025
OS-072-YI HBV integration can sustain HDV persistence especially in the setting of an absent HBV reservoir and can be a biomarker of response to bulevirtide
Journal of Hepatology·2025
page 1 of 8Next →

Frequent Co-authors

Patrick Kennedy(40), Mala K. Maini(17), Antonio Bertoletti(11), Laura J. Pallett(11), Dimitra Peppa(9), Anna Schurich(7), Navjyot Hansi(6), Brian R Davidson(6), Nina Le Bert(6), Harsimran Singh(5), Graham R. Foster(5), Giuseppe Fusai(5), Alice R. Burton(4), Anthony T. Tan(4), Valentina Svicher(4), Romina Salpini(4), Lorenzo Piermatteo(4), Carla Usai(4), Michelle Hong(3), Alberto Quaglia(3)